Kestra Medical Technologies (KMTS) Current Deferred Revenue (2025)
Kestra Medical Technologies (KMTS) posted quarterly Current Deferred Revenue of $460000.0 for Q1 2025.
Kestra Medical Technologies (KMTS) Current Deferred Revenue (2025) Analysis & Trends
Kestra Medical Technologies (KMTS) has reported Current Deferred Revenue for 1 consecutive years, with $460000.0 the latest figure, recorded in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Kestra Medical Technologies | 1.45 Bn | 1.10 Bn | 15.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2025 | 460,000.00 |